Delhi HC Reserves Order On Doctors’ Plea Against Ramdev Over Coronil

New Delhi: The Delhi High Court on Tuesday reserved its order on a plea by several doctors’ associations against yoga exponent Ramdev over his alleged “unsubstantiated” claim about ‘Coronil’ being a “cure” for COVID-19 and not just an immunity booster. The plea forms part of a 2021 lawsuit by doctors’ associations against the yoga guru, his aide Acharya Balkrishna as well as Patanjali Ayurveda founded by Ramdev, and seeks an interim relief of removal of statements from various media platforms with respect to the claim.

According to the lawsuit, Ramdev made unsubstantiated claims about ‘Coronil’ being a cure for COVID-19, contrary to the licence granted to the drug for merely being an immune-booster.

The senior counsel appearing for the plaintiffs also sought a direction to restrain the defendants from making further similar statements. Ramdev’s senior lawyer said he was bound by the undertaking given in the Supreme Court in the case concerning advertisements of Patanjali products, adding that he was willing to make a similar statement in the high court as well.

The plaintiffs’ senior lawyer, however, urged the court to pass an order on the interim application stating that the undertaking before the apex court was with regard to not making “causal statements” that are not in compliance with the law. Justice Anup Jairam Bhambhani said the matter before him concerned “specific instances” and reserved the order.

Three Resident Doctors’ Association of the All India Institute of Medical Sciences at Rishikesh, Patna and Bhubaneswar as well as Association of Resident Doctors, Post Graduate Institute of Medical Education & Research, Chandigarh; Union of Resident Doctors of Punjab (URDP); Resident Doctors’ Association, Lala Lajpat Rai Memorial Medical College, Meerut, and Telangana Junior Doctors’ Association, Hyderabad had moved the high court in 2021 against Ramdev and others.

In their lawsuit filed through advocate Harshavardhan Kotla, the associations have submitted that the yoga guru, who is a highly influential person, was sowing doubts in the minds of the general public about the safety and efficacy of not only allopathic treatments but also COVID-19 vaccines. They alleged that the “misinformation” campaign was nothing but an advertisement and marketing strategy to further the sales of the product sold by Ramdev, including ‘Coronil’, which he claimed to be an alternative treatment for COVID-19. On October 27, 2021, the high court had issued summons to Ramdev and others on the lawsuit, saying it was not a frivolous matter and a case was definitely made out for its institution.

Related Posts

Lipid Association Of India Issues New Updated Heart Disease Guidelines For Indian Patients

New Delhi: The Lipid Association of India (LAI) has updated its guidelines on heart disease in Indians, ToI reported on February 24. The fresh guidelines include new data on cardiovascular…

AI in Education is Transforming Learning Experiences

Artificial Intelligence (AI) is reshaping the landscape of education, offering personalized learning experiences and innovative teaching methods. This post delves into the various applications of AI in education, from adaptive…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Spurious Drug Factory Busted In Gandhinagar

Spurious Drug Factory Busted In Gandhinagar

DCA Seizes Overpriced, Misleading Claim Medicine

DCA Seizes Overpriced, Misleading Claim Medicine

DoP Further Expands List Of Special Invitees Into Committee Constituted To Reform Pricing Framework

DoP Further Expands List Of Special Invitees Into Committee Constituted To Reform Pricing Framework

India Key Market For APIs, But Patients Forced To Cough Up Crores To Buy Orphan Drugs

India Key Market For APIs, But Patients Forced To Cough Up Crores To Buy Orphan Drugs

Govt Considers Ban On Two Antibiotics For Poultry And Animal Feed Supplements

Govt Considers Ban On Two Antibiotics For Poultry And Animal Feed Supplements

PLI Scheme Review Committee Raises Concern Over Delays In Payments

PLI Scheme Review Committee Raises Concern Over Delays In Payments